Aktive Positionen von Ashleigh Barreto
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Investor Relations Kontakt | 01.10.2021 | - |
| Public Communications Contact | 01.10.2021 | - |
Karriereverlauf von Ashleigh Barreto
Ehemalige bekannte Positionen von Ashleigh Barreto
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ADAMAS PHARMACEUTICALS, INC. | Investor Relations Kontakt | - | 01.12.2018 |
| Public Communications Contact | - | 01.12.2018 | |
| XOMA CORPORATION | Investor Relations Kontakt | - | - |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Investor Relations Contact | 3 |
| Public Communications Contact | 2 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| XOMA CORPORATION | Health Technology |
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
- Börse
- Insiders
- Ashleigh Barreto
- Erfahrung
